ATHERSYS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATHERSYS INC and buy or sell other stocks, ETFs, and their options commission-free!

About ATHXQ

Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. 

CEO
Daniel A. Camardo, MBA
CEODaniel A. Camardo, MBA
Employees
24
Employees24
Headquarters
Cleveland, Ohio
HeadquartersCleveland, Ohio
Founded
1995
Founded1995
Employees
24
Employees24

ATHXQ Key Statistics

Market cap
6.17K
Market cap6.17K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
26.25K
Average volume26.25K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, ATHERSYS INC(ATHXQ) shares are valued at $0.00. The company's market cap stands at 6.17K.

On 2026-08-22, ATHERSYS INC(ATHXQ) stock opened at —, reached a high of —, and a low of —.

The ATHERSYS INC(ATHXQ)'s current trading volume is 0, compared to an average daily volume of 26.25K.

In the last year, ATHERSYS INC(ATHXQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

In the last year, ATHERSYS INC(ATHXQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.

People also own

Based on the portfolios of people who own ATHXQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.